+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market 2019-2025

  • PDF Icon

    Report

  • December 2019
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 4896944
UP TO OFF until Dec 31st 2022
Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report by technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software) By Application (Clinical Application, Research Application, and Forensic Application), Forecast Period 2019-2025.

The digital PCR and real-time PCR is anticipated to grow at a CAGR of 8.0% during the forecast period. QPCR and qPCR is a technology that is used in the gene-based analysis for cytological samples and has the application in the clinical diagnostics. The factors contributing to the growth of digital PCR and real-time PCR market includes increasing incidence of target diseases such as malaria, cancer, tuberculosis, and HIV, growing used of biomarker profiling for monitoring and diagnosis, successful completion of human genome sequencing and ongoing technological advancement in PCR technologies. Moreover, inorganic growth strategies that include mergers and acquisition through PCR manufacturers to enhance their product portfolio and incorporation of novel QPCR products is propelling the growth of dPCR and qPCR market.

The global digital PCR and real-time PCR industry are segmented on the basis of technology, application, and product. On the basis of technology, the market is segmented into digital PCR and quantitative PCR. Based on the application, the market is segmented into clinical application, research application, and forensic application. Based on product, the market is segmented into reagents and consumables, instruments and software. The market is further segmented based on geography including North America, Europe, Asia-Pacific and Rest of the World. The market in Asia-Pacific is expected to be the fastest-growing region mainly due to the large prevalence of chronic and infectious diseases with raising awareness in the patients regarding early diagnosis of diseases is boosting the demand for digital PCR and real-time PCR market.

The key players of digital PCR and real-time PCR market include Agilent Technologies, Inc., BioMérieux S.A., Fluidigm Corp., Abbott Laboratories, Inc., Merck KGaA, Becton Dickinson and Company, Thermo Fisher Scientific Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc., and Siemens AG.

Research Methodology

The market study of the global digital PCR and real-time PCR market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for dental hospitals, industrial manufacturers and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. Global Digital PCR and real-time PCR Market Research and Analysis by Technology
2. Global Digital PCR and real-time PCR Market Research and Analysis by Products
3. Global Digital PCR and real-time PCR Market Research and Analysis by Application
4. Global Digital PCR and real-time PCR Market Research and Analysis by End-Users
The Report Covers
  • Comprehensive research methodology of the global digital PCR and real-time PCR market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global digital PCR and real-time PCR market.
  • Insights about market determinants which are stimulating the global digital PCR and real-time PCR market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Abbott Laboratories, Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Agilent Technologies, Inc.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Qiagen N.V.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Bio-Rad Laboratories, Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Thermo Fisher Scientific, Inc.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.1. Opportunities
5. Market Segmentation
5.1. Global Digital PCR & Real Time PCR Market by Technology
5.1.1. Quantitative PCR
5.1.2. Digital PCR
5.2. Global Digital PCR & Real Time PCR Market by Product
5.2.1. Reagents and Consumables
5.2.2. Instruments
5.2.3. Software
5.3. Global Digital PCR & Real Time PCR Market by Application
5.3.1. Clinical Application
5.3.2. Research Application
5.3.3. Forensic Application
6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. Agilent Technologies, Inc.
7.3. Analytik Jena AG
7.4. Avance Biosciences
7.5. Becton Dickinson and Co.
7.6. Biodesix, Inc.
7.7. BioMérieux S.A.
7.8. Bio-Rad Laboratories, Inc.
7.9. Danaher Corporation
7.10. Eppendorf AG
7.11. F. Hoffmann-La Roche AG
7.12. Fluidigm Corp.
7.13. JN Medsys
7.14. Merck KGaA
7.15. Promega Corp.
7.16. QIAGEN N.V.
7.17. Quantabio
7.18. Siemens AG
7.19. Takara Bio, Inc.
7.20. Thermo Fisher Scientific, Inc.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc. Agilent Technologies, Inc.
  • Analytik Jena AG
  • Avance Biosciences
  • Becton Dickinson and Co.
  • Biodesix, Inc.
  • BioMérieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Eppendorf AG
  • F. Hoffmann-La Roche AG
  • Fluidigm Corp.
  • JN Medsys
  • Merck KGaA
  • Promega Corp.
  • QIAGEN N.V.
  • Quantabio
  • Siemens AG
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.